Co-delivery of curcumin and serratiopeptidase in HeLa and MCF-7 cells through nanoparticles show improved anti-cancer activity
Creators
- 1. Department of Biochemical Engineering and Biotechnology, Indian Institute of Technology Delhi, Hauz Khas, New Delhi (India)
Description
Highlights: • Anti-cancer activity of curcumin-serratiopeptidase nanoparticles was evaluated. • Serratiopeptidase acted as a carrier as well as bioactive molecule in the nanoformulations. • MTT assay, DAPI staining, ROS production and DNA damage has demonstrated anti-cancer activity of Cur-SPD NPs. • Release of serratiopeptidase and serratiopeptidase stabilised curcumin occurred in vitro through these nanoparticles. • Serratiopeptidase has a potential to serve as a model protein for encapsulating drugs in nanoformulations. - Abstract: Curcumin was employed to prepare anticancer nanoparticles (size 175 ± 15 nm) using anti-inflammatory enzyme serratiopeptidase by desolvation method. Here serratiopeptidase acted as a carrier as well as bioactive molecule in the nanoformulations. The Cur-SPD NPs (curcumin loaded serratiopeptidase nanoparticles) were characterized using DLS, FESEM and FTIR. The in vitro release behavior depicted biphasic pattern at 37 °C (pH 7.4) and release of 95% of both molecules occurred in 24 h. Serratiopeptidase not only provided stability to curcumin but also increased its effectiveness against cancer cells. These nanoparticles had anti-cancer activity in MCF-7 and HeLa cell lines as shown by cytotoxicity assay, DAPI nuclear staining, ROS production and DNA damage. The immunomodulatory tests showed that Cur-SPD NPs reduce level of IL-6 but increase TNFα level in THP1 cell lines. Structural similarity of serratiopeptidase to matrix metallo proteases (MMPs), particularly MMP8, have been found (based on low RMSD values) to induce TNFα production and play tumour suppressive role in certain cancers. Thus anti-cancer properties of Cur-SPD NPs may be attributed to synergistic effect of curcumin and serratiopeptidase. Thus results in present investigation provide an insight on role of serratiopeptidase in development of co-delivery of multifunctional nanoparticles with anti-cancer properties introduction.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.msec.2018.07.025Additional details
Identifiers
- DOI
- 10.1016/j.msec.2018.07.025;
- PII
- S0928493117344259;
Publishing Information
- Journal Title
- Materials Science and Engineering. C, Biomimetic Materials, Sensors and Systems
- Journal Volume
- 92
- Journal Page Range
- p. 673-684
- ISSN
- 0928-4931
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 50039659
- Subject category
- S60: APPLIED LIFE SCIENCES; S77: NANOSCIENCE AND NANOTECHNOLOGY;
- Descriptors DEI
- CURCUMIN; DNA DAMAGES; DRUG DELIVERY; DRUGS; ENZYMES; FOURIER TRANSFORM SPECTROMETERS; HELA CELLS; IN VITRO; INFLAMMATION; MOLECULES; NANOPARTICLES; NEOPLASMS; PH VALUE
- Descriptors DEC
- ANIMAL CELLS; AROMATICS; DISEASES; DYES; ETHERS; HYDROCARBONS; HYDROXY COMPOUNDS; KETONES; MEASURING INSTRUMENTS; ORGANIC COMPOUNDS; ORGANIC OXYGEN COMPOUNDS; PARTICLES; PATHOLOGICAL CHANGES; PHENOLS; POLYPHENOLS; PROTEINS; SPECTROMETERS; SYMPTOMS; TUMOR CELLS
Optional Information
- Copyright
- Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.